Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients

Journal of the Neurological Sciences

Volumn 284, Issue 1-2, 2009, Pages 36-39

  Tseng, Yu Lung ^a   Chang, Yung Yee ^a   Liu, Jia Shou ^a   Su, Chen San ^a   Lai, Shung Lon ^a   Lan, Min Yu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Homocysteine; Magnetic resonance imaging; Stroke; White matter

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; BRAIN INFARCTION; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STROKE; STROKE PATIENT; TAIWAN; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

ANIMALS; AXONS; BRAIN; CEREBRAL ARTERIAL DISEASES; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; OBESITY; PREVALENCE; RISK; SMOKING; STROKE; TAIWAN;

EID: 67949094319     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.03.030     Document Type: Article

References (35)

1. Jeerakathil T., Wolf P.A., Beiser A., Massaro J., Seshadri S., D'Agostino R.B., et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35 8 (2004) 1857-1861
2. Englund E. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 13 Suppl 2 (2002) 11-15
3. Tupler L.A., Coffey C.E., Logue P.E., Djang W.T., and Fagan S.M. Neuropsychological importance of subcortical white matter hyperintensity. Arch Neurol 49 12 (1992) 1248-1252
4. Kuller L.H., Longstreth Jr. W.T., Arnold A.M., Bernick C., Bryan R.N., and Beauchamp Jr. N.J. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 35 8 (2004) 1821-1825
5. Garde E., Lykke Mortensen E., Rostrup E., and Paulson O.B. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 76 9 (2005) 1289-1291
6. Adachi H., Hirai Y., Fujiura Y., Matsuoka H., Satoh A., and Imaizumi T. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 33 9 (2002) 2177-2181
7. Sasaki T., Watanabe M., Nagai Y., Hoshi T., Takasawa M., Nukata M., et al. Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction. Stroke 33 6 (2002) 1493-1496
8. Tsai M.Y., Arnett D.K., Eckfeldt J.H., Williams R.R., and Ellison R.C. Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis 151 2 (2000) 519-524
9. Eikelboom J.W., Hankey G.J., Anand S.S., Lofthouse E., Staples N., and Baker R.I. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31 5 (2000) 1069-1075
10. Tan N.C., Venketasubramanian N., Saw S.M., and Tjia H.T. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke 33 8 (2002) 1956-1962
11. Vermeer S.E., van Dijk E.J., Koudstaal P.J., Oudkerk M., Hofman A., Clarke R., et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 51 3 (2002) 285-289
12. Longstreth Jr. W.T., Katz R., Olson J., Bernick C., Carr J.J., Malinow M.R., et al. Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Arch Neurol 61 1 (2004) 67-72
13. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 226 1-2 (2004) 25-29
14. Scott T.M., Tucker K.L., Bhadelia A., Benjamin B., Patz S., Bhadelia R., et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry 12 6 (2004) 631-638
15. Wright C.B., Paik M.C., Brown T.R., Stabler S.P., Allen R.H., Sacco R.L., et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 36 6 (2005) 1207-1211
16. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging (2007), doi:10.1016/j.neurobiolaging.2007.08.023.
17. Wong A., Mok V., Fan Y.H., Lam W.W., Liang K.S., and Wong K.S. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. J Neurol 253 4 (2006) 441-447
18. Shimomura T., Anan F., Umeno Y., Eshima N., Saikawa T., Yoshimatsu H., et al. Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Neurol 15 3 (2008) 289-294
19. Leung S.Y., Ng T.H., Yuen S.T., Lauder I.J., and Ho F.C. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 24 6 (1993) 779-786
20. Liu F., Zhang B., and Tian Y. [Morphological changes in intracranial and extracranial arteries of autopsy cases of cerebrovascular diseases]. Zhonghua Yi Xue Za Zhi 76 11 (1996) 832-835
21. Ylikoski R., Ylikoski A., Erkinjuntti T., Sulkava R., Raininko R., and Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 50 8 (1993) 818-824
22. Lang D., Kredan M.B., Moat S.J., Hussain S.A., Powell C.A., Bellamy M.F., et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol 20 2 (2000) 422-427
23. Stamler J.S., Osborne J.A., Jaraki O., Rabbani L.E., Mullins M., Singel D., et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91 1 (1993) 308-318
24. Chen C., Halkos M.E., Surowiec S.M., Conklin B.S., Lin P.H., and Lumsden A.B. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res 88 1 (2000) 26-33
25. Nishinaga M., Ozawa T., and Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 92 3 (1993) 1381-1386
26. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 3 (2001) 613-621
27. Bots M.L., Launer L.J., Lindemans J., Hoes A.W., Hofman A., Witteman J.C., et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 159 1 (1999) 38-44
28. Iso H., Moriyama Y., Sato S., Kitamura A., Tanigawa T., Yamagishi K., et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 109 22 (2004) 2766-2772
29. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 2 (2006) 577-617
30. Tucker K.L., Qiao N., Scott T., Rosenberg I., and Spiro III A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 82 3 (2005) 627-635
31. Sacco R.L., Anand K., Lee H.S., Boden-Albala B., Stabler S., Allen R., et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke 35 10 (2004) 2263-2269
32. Hogervorst E., Ribeiro H.M., Molyneux A., Budge M., and Smith A.D. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59 5 (2002) 787-793
33. Naka H., Nomura E., Takahashi T., Wakabayashi S., Mimori Y., Kajikawa H., et al. Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types. AJNR Am J Neuroradiol 27 4 (2006) 830-835
34. Moretti R., Torre P., Antonello R.M., Manganaro D., Vilotti C., and Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag 4 2 (2008) 395-402
35. Pavloviċ A.M., Pekmezoviċ T., Zidverc-Trajkoviċ J., Pavloviċ D.M., Jovanovic Z., Mijajloviċ M., et al. Is there a difference in risk factors for single and multiple symptomatic lesions in small vessel disease? What is the difference between one and plenty-experience from 201 Serbian patients. Clin Neurol Neurosurg 108 4 (2006) 358-362